$2.3M sweet spot round size
Most of their 9 investments are in rounds between $1.1M and $3M
2018
Rarity Bioscience raised $539K on February 6, 2023
Investors: Novalis_Fund
Enzyre B.V. raised $12M on November 2, 2022
Investors: Advanced Endoscopy, i&i Biotech Fund, Takeda UK Limited, Oost NL and Novalis_Fund
Modality.AI raised $1.1M on October 7, 2022
Investors: Strathmere Healthcare Partners, Risk and Return, Relentless Venture Fund and Novalis_Fund
Carroucell raised $1.5M on September 7, 2022
Investors: Crédit Agricole d'Ile-de-France and Novalis_Fund
Trince raised $4.5M on December 4, 2021
Investors: Qbic and Novalis_Fund
Modality.AI raised $2.5M on July 30, 2021
Investors: Risk and Return, Strathmere Healthcare Partners, Relentless Venture Fund, Alchemist Accelerator, Voxel Ventures, Lair East Labs and Novalis_Fund
RheaVita BVBA raised $3M on June 2, 2021
Investors: Novalis_Fund
Grapheal raised $2.3M on February 10, 2021
Investors: Novalis_Fund
Enzyre B.V. raised $1.6M on July 27, 2020
Investors: Novalis_Fund